missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ CRACC/SLAMF7 Antibody (PDL241) - Humanized, Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals™ NBP3-28054-1mg

 View more versions of this product

Product Code. 30048197

  • € 920.00 / 1mg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CRACC/SLAMF7 Monoclonal antibody specifically detects CRACC/SLAMF7 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CRACC/SLAMF7
Monoclonal
Unconjugated
Q9NQ25
Human
Protein A purified
RUO
Primary
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Store at -20°C in powder form. Store at -80°C once reconstituted.
IgG1
Flow Cytometry, ELISA, Functional Assay
PDL241
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7
SLAMF7/ CS1
1 mg
Immunology
57823
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.